Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Gut|May 1, 1996
Hyperlipaemia intensifies the course of acute oedematous and acute necrotising pancreatitis in the ratB Hofbauer, H Friess, A Weber, et al.
Gastroenterology|December 3, 1998
Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitisC Bassi, M Falconi, G Talamini, et al.
Transplantation|July 17, 1998
Activation of the serine proteinase system in chronic kidney rejectionW H Tang, H Friess, F F di Mola, et al.
Digestion|January 1, 1997
ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancerJ P Neoptolemos, D J Kerr, H Beger, et al.
British Journal of Cancer|April 7, 2005
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancerD D Stocken, M W Büchler, C Dervenis, et al.
Digestive Surgery|November 19, 2005
Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trialC Bassi, D D Stocken, A Olah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Adjuvant therapy in pancreatic cancer: historical and current perspectivesJ P Neoptolemos, D Cunningham, H Friess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 1999
Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, A Zisiadis, U Dafni, et al.
Lancet (London, England)|November 22, 2001
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trialJ P Neoptolemos, J A Dunn, D D Stocken, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of LifeD Fitzsimmons, C D Johnson, S George, et al.
Pageof 4